Publication
Risk of severe allergic reactions to COVID‐19 vaccines among patients with allergic skin diseases – practical recommendations. A position statement of ETFAD with external experts
J. Ring, M. Worm, A. Wollenberg, J.P. Thyssen, T. Jakob, L. Klimek, C. Bangert, S. Barbarot, T. Bieber, M.S. de Bruin‐Weller, P.V. Chernyshov, S. Christen‐Zaech, M. Cork, U. Darsow, C. Flohr, R. Fölster‐Holst, C. Gelmetti, U. Gieler, J. Gutermuth, A. Heratizadeh, D.J. Hijnen, L.B. von Kobyletzki, B. Kunz, C. Paul, L. De Raeve, J. Seneschal, D. Simon, P.I. Spuls, J.F. Stalder, A. Svensson, Z. Szalai, A. Taieb, A. Torrelo, M. Trzeciak, C. Vestergaard, T. Werfel, S. Weidinger, M. Deleuran
Journal of the European Academy of Dermatology and Venereology, April 2021, Wiley
DOI: 10.1111/jdv.17237